245 related articles for article (PubMed ID: 26768092)
1. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
2. Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
Taghipour M; Sheikhbahaei S; Trahan TJ; Subramaniam RM
Nucl Med Commun; 2016 Jun; 37(6):602-8. PubMed ID: 27110955
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Taghipour M; Mena E; Kruse MJ; Sheikhbahaei S; Subramaniam RM
Nucl Med Commun; 2017 Mar; 38(3):250-258. PubMed ID: 28099264
[TBL] [Abstract][Full Text] [Related]
4. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
[TBL] [Abstract][Full Text] [Related]
6. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
[TBL] [Abstract][Full Text] [Related]
7. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
Marcus C; Antoniou A; Rahmim A; Ladenson P; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):281-8. PubMed ID: 25676871
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Marcus C; Marashdeh W; Ahn SJ; Taghipour M; Subramaniam RM
J Nucl Med; 2015 Jul; 56(7):989-94. PubMed ID: 25952738
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
Bird T; Barrington S; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1239-47. PubMed ID: 26707387
[TBL] [Abstract][Full Text] [Related]
12. Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.
Mena E; Taghipour M; Sheikhbahaei S; Jha AK; Rahmim A; Solnes L; Subramaniam RM
Clin Nucl Med; 2017 May; 42(5):e227-e234. PubMed ID: 28195905
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
[TBL] [Abstract][Full Text] [Related]
14. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study.
Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Truong MT; Sakai O
Eur J Radiol; 2020 May; 126():108936. PubMed ID: 32171912
[TBL] [Abstract][Full Text] [Related]
16. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
[TBL] [Abstract][Full Text] [Related]
17. Volumetric
Chotchutipan T; Rosen BS; Hawkins PG; Lee JY; Saripalli AL; Thakkar D; Eisbruch A; El Naqa I; Mierzwa ML
Head Neck; 2019 Feb; 41(2):366-373. PubMed ID: 30548704
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Mena E; Taghipour M; Sheikhbahaei S; Mirpour S; Xiao J; Subramaniam RM
Clin Nucl Med; 2016 Sep; 41(9):e403-9. PubMed ID: 27355846
[TBL] [Abstract][Full Text] [Related]
19. CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Rosen BS; Wilkie JR; Sun Y; Ibrahim M; Casper KA; Miller JE; Chotchutipan T; Stucken CL; Bradford C; Prince MEP; Rosko AJ; Malloy KM; McLean SA; Chinn SB; Shuman AG; Spector ME; Swiecicki PL; Worden FP; Shah JL; Schonewolf CA; Chapman CH; Eisbruch A; Mierzwa ML
Radiother Oncol; 2021 Feb; 155():174-181. PubMed ID: 33069764
[TBL] [Abstract][Full Text] [Related]
20. Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.
Paidpally V; Tahari AK; Lam S; Alluri K; Marur S; Koch W; Wahl RL; Subramaniam RM
J Nucl Med; 2013 Dec; 54(12):2039-45. PubMed ID: 24101687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
